These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 28803725)

  • 1. Schistosomiasis: Drugs used and treatment strategies.
    Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
    Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
    da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
    Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
    Alwan SN; Taylor AB; Rhodes J; Tidwell M; McHardy SF; LoVerde PT
    PLoS Pathog; 2023 Jul; 19(7):e1011018. PubMed ID: 37428793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    Infect Dis Poverty; 2018 Jul; 7(1):73. PubMed ID: 29986763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis.
    Gryseels B
    Infect Dis Clin North Am; 2012 Jun; 26(2):383-97. PubMed ID: 22632645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study.
    Kokaliaris C; Garba A; Matuska M; Bronzan RN; Colley DG; Dorkenoo AM; Ekpo UF; Fleming FM; French MD; Kabore A; Mbonigaba JB; Midzi N; Mwinzi PNM; N'Goran EK; Polo MR; Sacko M; Tchuem Tchuenté LA; Tukahebwa EM; Uvon PA; Yang G; Wiesner L; Zhang Y; Utzinger J; Vounatsou P
    Lancet Infect Dis; 2022 Jan; 22(1):136-149. PubMed ID: 34863336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis elimination by 2020 or 2030?
    Fenwick A; Jourdan P
    Int J Parasitol; 2016 Jun; 46(7):385-8. PubMed ID: 26907938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human schistosomiasis.
    Gryseels B; Polman K; Clerinx J; Kestens L
    Lancet; 2006 Sep; 368(9541):1106-18. PubMed ID: 16997665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise of antimicrobial peptides for treatment of human schistosomiasis.
    Oyinloye B; Adenowo F; Gxaba N; Kappo A
    Curr Drug Targets; 2014; 15(9):852-9. PubMed ID: 25101908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis.
    Cribb DM; Clarke NE; Doi SAR; Vaz Nery S
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007808. PubMed ID: 31603895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosomiasis-from immunopathology to vaccines.
    McManus DP; Bergquist R; Cai P; Ranasinghe S; Tebeje BM; You H
    Semin Immunopathol; 2020 Jun; 42(3):355-371. PubMed ID: 32076812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis.
    Spangenberg T
    ACS Infect Dis; 2021 May; 7(5):939-942. PubMed ID: 32819092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
    Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
    ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.
    Thiong'o FW; Mbugua GG; Ouma JH; Sturrock RK
    East Afr Med J; 2002 Jan; 79(1):29-33. PubMed ID: 12380867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?
    Aruleba RT; Adekiya TA; Oyinloye BE; Masamba P; Mbatha LS; Pretorius A; Kappo AP
    Infect Disord Drug Targets; 2019; 19(4):337-349. PubMed ID: 30599112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Schistosomiasis: diagnosis and treatment].
    Ripert C
    Presse Med; 2000 Sep; 29(28):1583-5. PubMed ID: 11072382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.